New developments in macrolides: structures and antibacterial and prokinetic activities.
Lartey
P A
PA
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.
Nellans
H N
HN
Tanaka
S K
SK
D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011964:Receptors, Gastrointestinal Hormone / Q000187:drug effects; D018013:Receptors, Neuropeptide / Q000187:drug effects; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D011500:Protein Synthesis Inhibitors; D011964:Receptors, Gastrointestinal Hormone; D018013:Receptors, Neuropeptide; C050802:motilin receptor; D004917:Erythromycin; D003577:Cytochrome P-450 Enzyme System